In Brief: Clinical hold review committee
Executive Summary
Clinical hold review committee: Will meet in October to examine requests by companies to review clinical trials placed on hold during the past 12 months, according to an Aug. 23 Federal Register notice. Companies must submit review requests by Sept. 22 to FDA Chief Mediator and Ombudsman Amanda Pederson, Office of the Commissioner, FDA, Rm. 14-105, 5600 Fishers Lane, Rockville, Md. 20857...